首页> 外文期刊>EJNMMI Research >Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study
【24h】

Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study

机译:正电子发射断层扫描-磁共振成像(PET-MRI)用于子宫颈癌放射治疗后的反应评估:一项先导研究

获取原文
           

摘要

Background Advanced stage cervical cancer is primarily treated by radiotherapy. Local tumor control is a prerequisite for cure. Imaging after treatment is controversial. Positron emission tomography (PET) combined with computer tomography (PET-CT) shows great promise for detecting metastases. On the other hand, magnetic resonance imaging (MRI) is superior in depicting anatomical details. The combination of PET-MRI could result in more accurate evaluation of cervical cancer treatment outcome. The aim of this pilot study is to share our initial experience with PET-MRI in the evaluation of treatment response in cervical cancer after radiation treatment. Methods Ten patients with cervical carcinoma (FIGO ≥IB2) were prospectively evaluated. Eleven weeks (median; range 8–15?weeks) after radiation therapy, treatment response was evaluated by PET-MRI. The PET, MRI, and combined PET-MRI images were evaluated for the presence of local residual tumor and metastasis. Diagnostic performance was assessed by area under the receiver operator characteristic (ROC) curve for evaluation of local residual tumor. The readers were blinded for outcome data. Local residual disease, metastasis, diagnostic confidence, and change of opinion were scored on a 5-point Likert scale. The reference standard consisted of pathology and/or follow-up according to the clinical guidelines. Results Three out of ten patients had local residual abnormalities suggestive for tumor residue after radiation treatment. The availability of both PET and MRI resulted in an increase in diagnostic confidence in 80–90% of all patients. Change of opinion was observed in 70% and change of policy in 50%, especially in the group with residual tumor. The diagnostic accuracy increased significantly for the radiologist if PET-MRI was combined (AUC .54 versus .83). Conclusions PET-MRI shows promise for evaluation of treatment response after radiation for cervical cancer, especially increasing diagnostic confidence, while potentially increasing diagnostic performance.
机译:背景技术晚期宫颈癌主要通过放射疗法治疗。局部肿瘤控制是治愈的前提。治疗后的影像学有争议。正电子发射断层扫描(PET)与计算机断层扫描(PET-CT)结合显示出检测转移的巨大希望。另一方面,磁共振成像(MRI)在描绘解剖细节方面表现优异。 PET-MRI的组合可以更准确地评估宫颈癌的治疗结果。这项初步研究的目的是与我们分享PET-MRI在评估放射治疗后宫颈癌的治疗反应方面的初步经验。方法对10例宫颈癌(FIGO≥IB2)进行前瞻性评估。放射治疗后十一周(中位数;范围为8-15周),通过PET-MRI评估治疗反应。评价PET,MRI和PET-MRI组合图像是否存在局部残留肿瘤和转移。通过在接收者操作员特征(ROC)曲线下的面积评估诊断性能,以评估局部残留肿瘤。读者对结果数据视而不见。局部残存疾病,转移,诊断置信度和观点变化以5分Likert量表评分。根据临床指南,参考标准包括病理和/或随访。结果十分之三的患者存在局部残留异常,提示放射治疗后存在肿瘤残留。 PET和MRI的可用性使所有患者中80-90%的诊断可信度增加。观察到意见改变的占70%,政策改变的占50%,特别是在残留肿瘤的患者中。如果将PET-MRI结合使用,放射科医生的诊断准确性将大大提高(AUC .54与.83)。结论PET-MRI显示出有希望评估子宫颈癌放疗后的治疗反应,特别是增加诊断置信度,同时潜在地提高诊断性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号